Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,504 | -18,272 | 63,726 | -7,753 | 16,999 |
| Depreciation Amortization | 3,045 | 493 | 305 | 980 | 1,872 |
| Income taxes - deferred | 1,520 | N/A | -49,200 | N/A | N/A |
| Accounts receivable | -7,352 | -4,444 | -7,385 | 3,766 | -2,648 |
| Accounts payable and accrued liabilities | 3,315 | 907 | 2,896 | -5,524 | 5,166 |
| Other Working Capital | -2,801 | 37,219 | 5,946 | -17,119 | -6,908 |
| Other Operating Activity | 48,854 | 20,194 | 15,833 | 1,845 | -1,152 |
| Operating Cash Flow | $38,077 | $36,097 | $32,121 | $-23,805 | $13,329 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,395 | -1,562 | -790 | -3,313 | -804 |
| Net Acquisitions | -23,534 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -166,822 | -148,954 | -149,852 | -134,638 | -112,838 |
| Sale Of Investment | 161,505 | 137,541 | 144,347 | 144,171 | 79,666 |
| Purchase Sale Intangibles | -2,000 | -14,929 | N/A | N/A | N/A |
| Other Investing Activity | -2,000 | -19,929 | 0 | 0 | 0 |
| Investing Cash Flow | $-50,246 | $-32,904 | $-6,295 | $6,220 | $-33,976 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,542 | 9,330 | 23,965 | 6,825 | 13,725 |
| Financing Cash Flow | $5,542 | $9,330 | $23,965 | $6,825 | $13,725 |
| Exchange Rate Effect | -482 | 74 | 33 | -39 | 25 |
| Beginning Cash Position | 88,127 | 75,530 | 25,706 | 36,505 | 43,402 |
| End Cash Position | 81,018 | 88,127 | 75,530 | 25,706 | 36,505 |
| Net Cash Flow | $-7,109 | $12,597 | $49,824 | $-10,799 | $-6,897 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,077 | 36,097 | 32,121 | -23,805 | 13,329 |
| Capital Expenditure | -19,395 | -1,571 | -790 | -3,313 | -804 |
| Free Cash Flow | 18,682 | 34,526 | 31,331 | -27,118 | 12,525 |